Piper Jaffray Reiterates Overweight and PT of $6 on TranS1

Piper Jaffray reiterated its Overweight rating on TranS1 TSON. At the same time, the rating agency left its price target on the company's stock unchanged at $6. On Thursday, TranS1 ended the day at $4.58.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: ReiterationAnalyst RatingsHealth CareHealth Care SuppliesPiper Jaffraytrans1
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!